Abstract
Place plays a significant role in our health. As genetic/genomic services evolve and are increasingly seen as mainstream, especially within the field of rare disease, it is important to ensure that where one lives does not impede access to genetic/genomic services. Our aim was to identify barriers and enablers of geographical equity in accessing clinical genomic or genetic services. We undertook a systematic review searching for articles relating to geographical access to genetic/genomic services for rare disease. Searching the databases Medline, EMBASE and PubMed returned 1803 papers. Screening led to the inclusion of 20 articles for data extraction. Using inductive thematic analysis, we identified four themes (i) Current service model design, (ii) Logistical issues facing clinicians and communities, (iii) Workforce capacity and capability and iv) Rural culture and consumer beliefs. Several themes were common to both rural and urban communities. However, many themes were exacerbated for rural populations due to a lack of clinician access to/relationships with genetic specialist staff, the need to provide more generalist services and a lack of genetic/genomic knowledge and skill. Additional barriers included long standing systemic service designs that are not fit for purpose due to historically ad hoc approaches to delivery of care. There were calls for needs assessments to clarify community needs. Enablers of geographically equitable care included the uptake of new innovative models of care and a call to raise both community and clinician knowledge and awareness to demystify the clinical offer from genetics/genomics services.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout


Similar content being viewed by others
Data availability
All data generated or analysed during this study are included in this published article [and its supplementary information files].
References
Dummer TJB. Health geography: supporting public health policy and planning. Can Med Assoc J. 2008;178:1177–80.
National Academies of Sciences Engineering and Medicine; Health and Medicine Division; Board on Health Care Services; Committee on Health Care Utilization and Adults with Disabilities. Factors that affect health-care utilization. In: Health-care utilization as a proxy in disability determination. Washington DC: National Academies Press (US); 2018.
Moy E, Garcia MC, Bastian B, Rossen LM, Ingram DD, Faul M, et al. Leading causes of death in nonmetropolitan and metropolitan areas, 1999–2014, CDC. Morbid Mortal Week Rep. 2017;66.
Henley SJ, Jemal A. Rural cancer control: bridging the chasm in geographic health inequity. HHS Public Access. 2018;27:1248–51.
Rocha TAH, Da Silva NC, Amaral PV, Barbosa ACQ, Rocha JVM, Alvares V, et al. Addressing geographic access barriers to emergency care services: a national ecologic study of hospitals in Brazil. Int J Equity Health. 2017;16:1–10.
Neale J, Tompkins C, Sheard L. Barriers to accessing generic health and social care services: a qualitative study of injecting drug users. Health Soc Care Community. 2008;16:147–54.
Jacobs B, Ir P, Bigdeli M, Annear PL, Van, Damme W. Addressing access barriers to health services: an analytical framework for selecting appropriate interventions in low-income Asian countries. Health Policy Plan. 2012;27:288–300.
Bellaiche MMJ, Fan W, Walbert HJ, McClave EH, Goodnight BL, Sieling FH, et al. Disparity in access to oncology precision care: a geospatial analysis of driving distances to genetic counselors in the U.S. Front Oncol. 2012;11:689927. https://doi.org/10.3389/fonc.2021.689927.
Gardner B, Doose M, Sanchez JI, Freedman AN, Moor JSD. Distribution of genomic testing resources by oncology practice and rurality: a nationally representative study. JCO Precis Oncol. 2021;5:1060–8. https://doi.org/10.1200/po.21.00109.
National Academies of Sciences Engineering and Medicine. Understanding disparities in access to genomic medicine. Washington DC: The National Academies Press; 2018. 126.
Barwell JG, Sullivan RBGO, Mansbridge LK, Lowry JM, Dorkins HR. Challenges in implementing genomic medicine: the 100,000 Genomes Project. J Transl Genet Genom. 2018;2:13.
Best S, Brown H, Stark Z, Long JC, Ng L, Braithwaite J, Taylor N. Teamwork in clinical genomics: A dynamic sociotechnical healthcare setting. J Eval Clin Pract. 2021;27:1369–80. https://doi.org/10.1111/jep.13573. Epub 2021 May 5.
Stark Z, Dolman L, Manolio TA, Ozenberger B, Hill SL, Caulfied MJ, et al. Integrating genomics into healthcare: a global responsibility. Am J Hum Genet. 2019;104:13–20.
Wise AL, Manolio TA, Mensah GA, Peterson JF, Roden DM, Tamburro C, et al. Genomic medicine for undiagnosed diseases. Lancet. 2019;394:533–40.
Manolio TA, Chisholm RL, Ozenberger B, Roden DM, Williams MS, Wilson R, et al. Implementing genomic medicine in the clinic: the future is here. Genet Med. 2013;15:258–67.
Mattick JS, Dziadek MA, Terrill BN, Kaplan W, Spigelman AD, Bowling FG, et al. The impact of genomics on the future of medicine and health. Med J Aust. 2014;201:17–20.
Borzekowski DL, Guan Y, Smith KC, Erby LH, Roter DL. The Angelina effect: immediate reach, grasp, and impact of going public. Genet Med. 2014;16:516–21.
Carmichael N, Tsipis J, Windmueller G, Mandel L, Estrella E. “Is it going to hurt?” The impact of the diagnostic odyssey on children and their families. J Genet Couns. 2015;24:325–35. https://doi.org/10.1007/s10897-014-9773-9. Epub 2014 Oct 4.
Moher D, Liberati A, Tetzlaff J, Altman D TPGroup. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159.
Hawker S, Payne S, Kerr C, Hardey M, Powell J. Appraising the evidence: reviewing disparate data systematically. Qual Health Res. 2002;12:1284–99.
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.
Boothe E, Greenberg S, Delaney CL, Cohen SA. Genetic counseling service delivery models: a study of genetic counselors’ interests, needs, and barriers to implementation. J Genet Couns. 2020:1–10.
Harrison M, Birch S, Eden M, Ramsden S, Farragher T, Payne K, et al. Variation in healthcare services for specialist genetic testing and implications for planning genetic services: the example of inherited retinal dystrophy in the English NHS. J Community Genet. 2015;157–65.
Kaye C, Bodurtha J, Edick M, Ginsburg S, Keehn A, Lloyd-puryear M, et al. Regional models of genetic services in the United States. Genet Med [Internet]. 2020;22:381–8. Available from https://doi.org/10.1038/s41436-019-0648-1.
Triebold M, Skov K, Erickson L, Olimb S, Puumala S, Wallace I, et al. Geographical analysis of the distribution of certified genetic counselors in the United States. J Genet Couns. 2020;1–9.
Villegas C, Haga SB. Access to genetic counselors in the Southern United States. J Pers Med. 2019;9:33. https://doi.org/10.3390/jpm9030033.
Vieira TP, Sgardioli IC, Gil-da-silva-lopes VL. Genetics and public health: the experience of a reference center for diagnosis of 22q11. 2 deletion in Brazil and suggestions for implementing genetic testing. J Community Genet. 2013;4:99–106. https://doi.org/10.1007/s12687-012-0123-z.
Penon-Portmann M, Chang J, Cheng M, Shieh JT. Genetics workforce: distribution of genetics services and challenges to health care in California. Genet Med. 2020;22:227–31.
Burton H, Alberg C, Moore AT. Genetics in ophthalmology: equity in service provision? J Public Health (Oxf). 2010;32:259–66. https://doi.org/10.1093/pubmed/fdp110.
Senier L, Kearney M, Orne J. Using public-private partnerships to mitigate disparities in access to genetic services: lessons from Wisconsin. Adv Med Social. 2015;16:269–305.
Qian E. A comparative study of patients’ perceptions of genetic and genomic medicine services in California and Malaysia. J Community Genet. 2019;10:351–61. https://doi.org/10.1007/s12687-018-0399-8.
Cohen SA, Huziak RC, Gustafson S, Grubs RE. Analysis of advantages, limitations, and barriers of genetic counseling service delivery models. J Genet Couns. 2016;25:1010–8. https://doi.org/10.1007/s10897-016-9932-2.
Bucio D, Bustamante CD. A genetic counseling needs assessment of Mexico. Mol Genet Genom Med. 2019;7:e668. https://doi.org/10.1002/mgg3.668.
Cohen SA, Marvin ML, Riley BD, Vig HS, Rousseau JA, Gustafson SL. Identification of genetic counseling service delivery models in practice: a report from the NSGC Service Delivery Model Task Force. J Genet Couns. 2013;22:411–21. https://doi.org/10.1007/s10897-013-9588-0.
Hawkins AK, Creighton S, Hayden MR. When access is an issue: exploring barriers to predictive testing for Huntington disease in British Columbia, Canada. Eur J Hum Genet. 2013;21:148–53. https://doi.org/10.1038/ejhg.2012.147.
Terry AB, Wylie A, Raspa M, Vogel B, Sanghavi K, Djurdjinovic L, et al. Clinical models of telehealth in genetics: a regional telegenetics landscape. J Genet Couns. 2019;28:673–91. https://doi.org/10.1002/jgc4.1088.
Harding B, Webber C, Ruhland L, Dalgarno N, Armour CM, Birtwhistle R, et al. Primary care providers’ lived experiences of genetics in practice. J Community Genet. 2019;10:85–93. https://doi.org/10.1007/s12687-018-0364-6.
Dorfman E, Trinidad SB, Morales C, Howlett K, Burke W, Woodahl E. Pharmacogenomics in diverse practice settings: implementation beyond major. Pharmacogenomics. 2015;16:227–37.
Smith AJ, Oswald D, Bodurtha J. Trends in unmet need for genetic counseling among children with special health care needs, 2001–2010. Acad Pediatr. 2015;15:544–50.
Bernhardt BA, Zayac C, Pyeritz RE. Why is genetic screening for autosomal dominant disorders underused in families? The case of hereditary hemorrhagic telangiectasia. Genet Med. 2011;13:812–20. https://doi.org/10.1097/GIM.0b013e31821d2e6d.
Holloway SM, Lampe AK, Lam W. Paediatric referral and attendance rates for the clinical genetics service in south-east Scotland--a comparison of a regional clinic with satellite clinics. Scott Med J. 2010;55:10–3. https://doi.org/10.1258/RSMSMJ.55.1.10.
Blaes AH, Patricia IJ, McKay K, Riley D, Jatoi I, Trentham-Dietz A, et al. Factors associated with genetic testing in a cohort of breast cancer survivors. Breast J. 2019;25:1241–4.
Green RF, Ari M, Kolor K, Dotson WD, Bowen S, Habarta N, et al. Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework. Genet Med. 2019;21:28–37.
Lawrence-Bourne J, Dalton H, Perkins D, Farmer J, Luscombe G, Oelke N, et al. What is rural adversity, how does it affect wellbeing and what are the implications for action? Int J Environ Res Public Health. 2020;17:7205.
Page-Carruth A, Windsor C, Clark M. Rural self-reliance: the impact on health experiences of people living with type II diabetes in rural Queensland, Australia. Int J Qual Stud Health Well-Being. 2014;9:24182. https://doi.org/10.3402/qhw.v9.24182.
Brown EG, Watts I, Beales ER, Maudhoo A, Hayward J, Sheridan E, et al. Videoconferencing to deliver genetics services: a systematic review of telegenetics in light of the COVID-19 pandemic. Genet Med. 2021;23:1438–49. https://doi.org/10.1038/s41436-021-01149-2. Epub 2021 Apr 6.
Bonter K, Desjardins C, Currier N, Pun J, Ashbury FD. Personalised medicine in Canada: a survey of adoption and practice in oncology, cardiology and family medicine. BMJ Open. 2011;1:1–7.
Hamilton AB, Finley EP. Qualitative methods in implementation research: an introduction. Psychiatry Res. 2020. https://doi.org/10.1016/j.psychres.2019.112516.
Acknowledgements
The authors declare no competing financial interests in relation to the study described in the manuscript. Our study was funded through Australian Genomics, via an NHMRC Targeted Call for Research grant (GNT1113531): ‘Preparing Australia for Genomic Medicine’. The funders played no part in the study design; data collection, analysis, and interpretation; in the writing of the manuscript or in the decision to submit this manuscript for publication.
Author information
Authors and Affiliations
Contributions
SB was responsible for designing the review protocol, writing the protocol and report, screening eligible studies, extracting and analysing data, interpreting results, and lead the writing. NV supported designing the review protocol, screening eligible studies, extracting and analysing data, interpreting results and supported writing up the findings. KA liaised with the librarian, ran the searches, screening eligible studies, extracting and analysing data, interpreting results and supported writing up the findings. FC supported designing the protocol, provided expert opinion and criticism and writing up the findings. SMW supported designing the protocol, provided expert opinion and criticism and writing up the findings
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Best, S., Vidic, N., An, K. et al. A systematic review of geographical inequities for accessing clinical genomic and genetic services for non-cancer related rare disease. Eur J Hum Genet 30, 645–652 (2022). https://doi.org/10.1038/s41431-021-01022-5
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41431-021-01022-5
This article is cited by
-
Evidence of inequities experienced by the rare disease community with respect to receipt of a diagnosis and access to services: a scoping review of UK and international evidence
Orphanet Journal of Rare Diseases (2025)
-
“It’s a Godsend”: Parental experiences of genomic testing for paediatric inborn errors of immunity
European Journal of Human Genetics (2025)
-
Breaking barriers: fostering equitable access to pediatric genomics through innovative care models and technologies
Pediatric Research (2025)
-
Precision diagnostic and therapeutic interventions in rare genetic neurodevelopmental disorders
Pediatric Research (2025)
-
Determining the value of genomics in healthcare
Nature Medicine (2025)


